DK3313408T3 - Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt - Google Patents

Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt Download PDF

Info

Publication number
DK3313408T3
DK3313408T3 DK16731177.8T DK16731177T DK3313408T3 DK 3313408 T3 DK3313408 T3 DK 3313408T3 DK 16731177 T DK16731177 T DK 16731177T DK 3313408 T3 DK3313408 T3 DK 3313408T3
Authority
DK
Denmark
Prior art keywords
drospirenone
female patient
based contraceptive
overweight female
overweight
Prior art date
Application number
DK16731177.8T
Other languages
Danish (da)
English (en)
Inventor
Dominique Drouin
Cécile Boyer-Joubert
Philippe Perrin
Original Assignee
Laboratorios Leon Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56178376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3313408(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP15305965.4A external-priority patent/EP3108889A1/en
Priority claimed from CN201510348953.1A external-priority patent/CN106265694A/zh
Application filed by Laboratorios Leon Farma Sa filed Critical Laboratorios Leon Farma Sa
Application granted granted Critical
Publication of DK3313408T3 publication Critical patent/DK3313408T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK16731177.8T 2015-06-23 2016-06-23 Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt DK3313408T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305965.4A EP3108889A1 (en) 2015-06-23 2015-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight
CN201510348953.1A CN106265694A (zh) 2015-06-23 2015-06-23 用于过重女性患者的基于屈螺酮的避孕药
PCT/EP2016/064574 WO2016207298A1 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Publications (1)

Publication Number Publication Date
DK3313408T3 true DK3313408T3 (da) 2024-01-29

Family

ID=56178376

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16731177.8T DK3313408T3 (da) 2015-06-23 2016-06-23 Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt

Country Status (26)

Country Link
EP (1) EP3313408B1 (enExample)
JP (1) JP6827962B2 (enExample)
KR (1) KR102217942B1 (enExample)
CN (2) CN113750108B (enExample)
AU (1) AU2016282863B2 (enExample)
BR (1) BR112017028048A2 (enExample)
CA (1) CA2989975C (enExample)
DK (1) DK3313408T3 (enExample)
EA (1) EA036497B1 (enExample)
ES (1) ES2970532T3 (enExample)
FI (1) FI3313408T3 (enExample)
HR (1) HRP20240121T8 (enExample)
HU (1) HUE065350T2 (enExample)
LT (1) LT3313408T (enExample)
MX (1) MX389310B (enExample)
MY (1) MY187233A (enExample)
NI (1) NI201700173A (enExample)
PH (1) PH12017502379A1 (enExample)
PL (1) PL3313408T3 (enExample)
RS (1) RS65196B1 (enExample)
SI (1) SI3313408T1 (enExample)
SM (1) SMT202400062T1 (enExample)
SV (1) SV2017005602A (enExample)
UA (1) UA122873C2 (enExample)
WO (1) WO2016207298A1 (enExample)
ZA (1) ZA201800067B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
JP6827962B2 (ja) 2015-06-23 2021-02-10 ラボラトリオス レオン ファーマ エスエー 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
WO2004041288A1 (en) * 2002-11-05 2004-05-21 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
GT200500099A (es) * 2004-04-30 2006-05-05 Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
AR049707A1 (es) * 2004-07-07 2006-08-30 Wyeth Corp Regimenes y kits de progestina ciclica
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
ES2311927T5 (es) 2005-07-21 2014-09-08 Bayer Pharma Aktiengesellschaft Proceso para la producción de 3-oxo-pregn-4-en-21,17-carbolactonas por la oxidación sin metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos
UY31010A1 (es) * 2007-04-05 2008-11-28 Bayer Schering Pharma Ag Nuevo régimen de drospirenona/17b-estradiol, producto farmacéutico combinado y conjunto de elementos (kit) para su aplicacion
CN102395596B (zh) * 2010-03-16 2013-02-13 台州太法药业有限公司 屈螺酮制备方法
RU2422824C1 (ru) * 2010-05-07 2011-06-27 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
AR081670A1 (es) * 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
CN103372015A (zh) * 2012-04-19 2013-10-30 国家人口计生委科学技术研究所 包含屈螺酮或屈螺酮和雌激素的阴道环制剂
RU2527357C1 (ru) * 2013-08-02 2014-08-27 Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет
JP6827962B2 (ja) 2015-06-23 2021-02-10 ラボラトリオス レオン ファーマ エスエー 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬

Also Published As

Publication number Publication date
HUE065350T2 (hu) 2024-05-28
HRP20240121T1 (hr) 2024-04-12
HRP20240121T8 (hr) 2024-05-10
WO2016207298A1 (en) 2016-12-29
JP6827962B2 (ja) 2021-02-10
AU2016282863A1 (en) 2018-02-08
MY187233A (en) 2021-09-13
FI3313408T3 (fi) 2024-01-25
RS65196B1 (sr) 2024-03-29
HK1255216A1 (zh) 2019-08-09
MX389310B (es) 2025-03-20
CN113750108A (zh) 2021-12-07
PL3313408T3 (pl) 2024-04-15
CN108025014B (zh) 2021-10-22
UA122873C2 (uk) 2021-01-13
CA2989975A1 (en) 2016-12-29
LT3313408T (lt) 2024-03-12
CA2989975C (en) 2021-10-12
NI201700173A (es) 2018-04-02
AU2016282863B2 (en) 2021-05-27
EA036497B1 (ru) 2020-11-17
BR112017028048A2 (pt) 2018-09-04
ZA201800067B (en) 2019-07-31
MX2017016801A (es) 2018-05-11
PH12017502379A1 (en) 2018-06-25
ES2970532T3 (es) 2024-05-29
CN108025014A (zh) 2018-05-11
SI3313408T1 (sl) 2024-04-30
SV2017005602A (es) 2018-08-14
KR102217942B1 (ko) 2021-02-19
JP2018527305A (ja) 2018-09-20
EA201792595A1 (ru) 2018-06-29
EP3313408B1 (en) 2023-12-06
SMT202400062T1 (it) 2024-03-13
CN113750108B (zh) 2025-08-19
NZ739195A (en) 2024-04-26
KR20180019173A (ko) 2018-02-23
EP3313408A1 (en) 2018-05-02

Similar Documents

Publication Publication Date Title
IL263046A (en) 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
DK3722274T3 (da) 2-perfluorbutylpentan til oftalmisk indgivelse
HUE051862T2 (hu) Stabil, IFNAR1-elleni készítmény
EP3490474A4 (en) ORTHOPEDIC TIED IMPLANTS AND SYSTEM
DK3229810T3 (da) Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler
GB2555231B (en) Packing element back-up system incorporating iris mechanism
LT3313408T (lt) Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio
LT3390390T (lt) Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui
EP3164092C0 (en) MOBILE BONE PLATE IMPLANTATION SYSTEM
HUE054551T2 (hu) Ösztetrolt tartalmazó, szájban diszpergálódó tabletta
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
EP3242631A4 (en) Prosthesis for improved penis function
DK3486249T3 (da) 99mtc-edda/hynic-ipsma som et radiofarmaceutisk middel til detektering af overekspressionen af prostata-specifikt membranantigen
DK3578635T3 (da) Immunoassay, som anvender indfangningskonjugat
DK3394045T3 (da) Co-krystal, fremstillingsfremgangsmåde deraf og medikament som indeholder co-krystal.
BR112016019077A2 (pt) método para redução de interrupção de serviço.
EP3380049C0 (en) PROSTHESIS FOR PATIENTS WITH ENTEROSTOMY
DK3248597T3 (da) Terapeutisk middel til sensorineuralt høretab
DK3347360T3 (da) Forbindelser, som er anvendelige til inhibering af ror-gamma-t
DK3308781T3 (da) Antihypertensivt middel
PL3390450T3 (pl) Humanizowane przeciwciało anty-cd28 formułowane do podawania ludziom
DK3506956T3 (da) Lægemiddel, særlig til behandling af fistler
DK3070964T3 (da) Høreapparat, især hørehjælpeapparat.
LT3253749T (lt) Junginiai, pasižymintys priešnavikiniu aktyvumu
EP3167607A4 (en) Scene-by-scene plot context for cognitively impaired